Extracellular signal-regulated kinase 2 (ERK2) mediates phosphorylation and inactivation of nuclear interaction partner of anaplastic lymphoma kinase (NIPA) at G2/M

Journal of Biological Chemistry

Volumn 287, Issue 45, 2012, Pages 37997-38005

  Illert, Anna Lena ^a   Zech, Michael ^a   Moll, Cathrin ^a   Albers, Corinna ^a   Kreutmair, Stefanie ^a   Peschel, Christian ^a   Bassermann, Florian ^a   Duyster, Justus ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; CELL CYCLE REGULATION; EXTRACELLULAR SIGNAL-REGULATED KINASE; NUCLEAR INTERACTION;

ENZYMES;

PHOSPHORYLATION;

ANAPLASTIC LYMPHOMA KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NUCLEAR INTERACTION PARTNER OF ANAPLASTIC LYMPHOMA KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; G2 PHASE CELL CYCLE CHECKPOINT; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BUTADIENES; CELL CYCLE PROTEINS; CELL DIVISION; CELLS, CULTURED; ENZYME INHIBITORS; FLAVONOIDS; G2 PHASE; HEK293 CELLS; HUMANS; IMMUNOBLOTTING; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUTATION; NIH 3T3 CELLS; NITRILES; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN BINDING; RNA INTERFERENCE; SERINE;

EID: 84868314587     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.373464     Document Type: Article

References (65)

1. Bassermann, F., von Klitzing, C., Münch, S., Bai, R. Y., Kawaguchi, H., Morris, S. W., Peschel, C., and Duyster, J. (2005) NIPA defines an SCFtype mammalian E3 ligase that regulates mitotic entry. Cell 122, 45-577
2. Ouyang, T., Bai, R. Y., Bassermann, F., von Klitzing, C., Klumpen, S., Miething, C., Morris, S. W., Peschel, C., and Duyster, J. (2003) Identification and characterization of a nuclear interacting partner of anaplastic lymphoma kinase (NIPA). J. Biol. Chem. 278, 30028-300366
3. Bassermann, F., Peschel, C., and Duyster, J. (2005) Mitotic entry: a matter of oscillating destruction. Cell Cycle 4, 1515-15177
4. von Klitzing, C., Huss, R., Illert, A. L., Fröschl, A., Wötzel, S., Peschel, C., Bassermann, F., and Duyster, J. (2011) APC/CCdh1-mediated degradation of the F-box protein NIPA is regulated by its association with Skp1. PLoS ONE 6, e289988
5. Illert, A. L., Kawaguchi, H., Antinozzi, C., Bassermann, F., Quintanilla-Martinez, L., von Klitzing, C., Hiwatari, M., Peschel, C., de Rooij, D. G., Morris, S. W., Barchi, M., and Duyster, J. (2012) Targeted inactivation of nuclear interaction partner of ALK disrupts meiotic prophase. Development 139, 2523-25344
6. Bai, C., Sen, P., Hofmann, K., Ma, L., Goebl, M., Harper, J. W., and Elledge, S. J. (1996) SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell 86, 263-2744
7. Feldman, R. M., Correll, C. C., Kaplan, K. B., and Deshaies, R. J. (1997) A complex of Cdc4p, Skp1p, and Cdc53p/cullin catalyzes ubiquitination of the phosphorylated CDK inhibitor Sic1p. Cell 91, 221-2300
8. Skowyra, D., Craig, K. L., Tyers, M., Elledge, S. J., and Harper, J. W. (1997) F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex. Cell 91, 209-2199
9. Cardozo, T., and Pagano, M. (2004) The SCF ubiquitin ligase: insights into a molecular machine. Nat. Rev. Mol. Cell Biol. 5, 739-7511
10. Bassermann, F., von Klitzing, C., Illert, A. L., Münch, S., Morris, S. W., Pagano, M., Peschel, C., and Duyster, J. (2007) Multisite phosphorylation of nuclear interaction partner of ALK (NIPA) at G2/M involves cyclin B1/Cdk1. J. Biol. Chem. 282, 15965-159722
11. Chang, L., and Karin, M. (2001) Mammalian MAP kinase signaling cascades. Nature 410, 37-400
12. Hindley, A., and Kolch, W. (2002) Extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinase (MAPK)-independent functions of Raf kinases. J. Cell Sci. 115, 1575-15811
13. Kolch, W. (2005) Coordinating ERK/MAPK signaling through scaffolds and inhibitors. Nat. Rev. Mol. Cell Biol. 6, 827-8377
14. Dhillon, A. S., Hagan, S., Rath, O., and Kolch, W. (2007) MAP kinase signaling pathways in cancer. Oncogene 26, 3279-32900
15. Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., and Greenberg, M. E. (1995) Opposing effects of ERK and JNK p38 MAP kinases on apoptosis. Science 270, 1326-13311
16. Yoon, S., and Seger, R. (2006) The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 24, 21-444
17. MacNicol, A. M., Muslin, A. J., Howard, E. L., Kikuchi, A., MacNicol, M. C., and Williams, L. T. (1995) Regulation of Raf-1-dependent signaling during early Xenopus development. Mol. Cell. Biol. 15, 6686-66933
18. Murakami, M. S., and Vande Woude, G. F. (1998) Analysis of the early embryonic cell cycles of Xenopus; regulation of cell cycle length by Xewee1 and Mos. Development 125, 237-2488
19. Guadagno, T. M., and Ferrell, J. E., Jr. (1998) Requirement for MAPK activation for normal mitotic progression in Xenopus egg extracts. Science 282, 1312-13155
20. Chau, A. S., and Shibuya, E. K. (1999) Inactivation of p42 mitogen-activated protein kinase is required for exit fromMphase after cyclin destruction. J. Biol. Chem. 274, 32085-320900
21. Yamamoto, T., Ebisuya, M., Ashida, F., Okamoto, K., Yonehara, S., and Nishida, E. (2006) Continuous ERK activation down-regulates antiproliferative genes throughout G1 phase to allow cell cycle progression. Curr. Biol. 16, 1171-11822
22. Roberts, E. C., Shapiro, P. S., Nahreini, T. S., Pages, G., Pouyssegur, J., and Ahn, N. G. (2002) Distinct cell cycle timing requirements for extracellular signal-regulated kinase and phosphoinositide 3-kinase signaling pathways in somatic cell mitosis. Mol. Cell. Biol. 22, 7226-72411
23. Chambard, J. C., Lefloch, R., Pouysségur, J., and Lenormand, P. (2007) ERK implication in cell cycle regulation. Biochim. Biophys. Acta 1773, 1299-13100
24. Roovers, K., and Assoian, R. K. (2000) Integrating the MAP kinase signal into the G1 phase cell cycle machinery. BioEssays 22, 818-8266
25. Meloche, S., and Pouysségur, J. (2007) The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1-to-S phase transition. Oncogene 26, 3227-32399
26. Dumesic, P. A., Scholl, F. A., Barragan, D. I., and Khavari, P. A. (2009) Erk1/2 MAP kinases are required for epidermal G2/M progression. J. Cell Biol. 185, 409-4222
27. Wang, R., He, G., Nelman-Gonzalez, M., Ashorn, C. L., Gallick, G. E., Stukenberg, P. T., Kirschner, M. W., and Kuang, J. (2007) Regulation of Cdc25C by ERK-MAP kinases during the G2/M transition. Cell 128, 1119-11322
28. Liu, X., Yan, S., Zhou, T., Terada, Y., and Erikson, R. L. (2004) The MAP kinase pathway is required for entry into mitosis and cell survival. Oncogene 23, 763-7766
29. Lavoie, J. N., L'Allemain, G., Brunet, A., Müller, R., and Pouysségur, J. (1996) Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271, 20608-206166
30. Balmanno, K., and Cook, S. J. (1999) Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1, and a subset of AP-1 proteins in CCL39 cells. Oncogene 18, 3085-30977
31. Hayne, C., Tzivion, G., and Luo, Z. (2000) Raf-1/MEK/MAPK pathway is necessary for the G2/M transition induced by nocodazole. J. Biol. Chem. 275, 31876-318822
32. Tolwinski, N. S., Shapiro, P. S., Goueli, S., and Ahn, N. G. (1999) Nuclear localization of mitogen-activated protein kinase kinase 1 (MKK1) is promoted by serum stimulation and G2/M progression. Requirement for phosphorylation at the activation lip and signaling downstream of MKK. J. Biol. Chem. 274, 6168-61744
33. Zecevic, M., Catling, A. D., Eblen, S. T., Renzi, L., Hittle, J. C., Yen, T. J., Gorbsky, G. J., and Weber, M. J. (1998) Active MAP kinase in mitosis: localization at kinetochores and association with the motor protein CENP-E. J. Cell Biol. 142, 1547-15588
34. Kosako, H., Gotoh, Y., and Nishida, E. (1994) Requirement for the MAP kinase kinase/MAP kinase cascade in Xenopus oocyte maturation. EMBO J. 13, 2131-21388
35. Abrieu, A., Fisher, D., Simon, M. N., Dorée, M., and Picard, A. (1997) MAPK inactivation is required for the G2-to-M phase transition of the first mitotic cell cycle. EMBO J. 16, 6407-64133
36. Bitangcol, J. C., Chau, A. S., Stadnick, E., Lohka, M. J., Dicken, B., and Shibuya, E. K. (1998) Activation of the p42 mitogen-activated protein kinase pathway inhibits Cdc2 activation and entry intoMphase in cycling Xenopus egg extracts. Mol. Biol. Cell 9, 451-4677
37. Bhatt, R. R., and Ferrell, J. E., Jr. (1999) The protein kinase p90 Rsk as an essential mediator of cytostatic factor activity. Science 286, 1362-13655
38. Gross, S. D., Schwab, M. S., Lewellyn, A. L., and Maller, J. L. (1999) Induction of metaphase arrest in cleaving Xenopus embryos by the protein kinase p90Rsk. Science 286, 1365-13677
39. Albers, C., Illert, A. L., Miething, C., Leischner, H., Thiede, M., Peschel, C., and Duyster, J. (2011) An RNAi-based system for loss-of-function analysis identifies Raf-1 as a crucial mediator of BCR-ABL-driven leukemogenesis. Blood 118, 2200-22100
40. Favata, M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A., Feeser, W. S., Van Dyk, D. E., Pitts, W. J., Earl, R. A., Hobbs, F., Copeland, R. A., Magolda, R. L., Scherle, P. A., and Trzaskos, J. M. (1998) Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273, 18623-186322
41. Brummer, T., Naegele, H., Reth, M., and Misawa, Y. (2003) Identification of novel ERK-mediated feedback phosphorylation sites at the C terminus of B-Raf. Oncogene 22, 8823-88344
42. Pearson, G., Robinson, F., Beers Gibson, T., Xu, B. E., Karandikar, M., Berman, K., and Cobb, M. H. (2001) Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22, 153-1833
43. Ramos, J. W. (2008) The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells. Int. J. Biochem. Cell Biol. 40, 2707-27199
44. Shaul, Y. D., and Seger, R. (2007) The MEK/ERK cascade: from signaling specificity to diverse functions. Biochim. Biophys. Acta 1773, 1213-12266
45. Gonzalez, F. A., Raden, D. L., and Davis, R. J. (1991) Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases. J. Biol. Chem. 266, 22159-221633
46. Chuderland, D., and Seger, R. (2005) Protein-protein interactions in the regulation of the extracellular signal-regulated kinase. Mol. Biotechnol. 29, 57-744
47. Corbalan-Garcia, S., Yang, S. S., Degenhardt, K. R., and Bar-Sagi, D. (1996) Identification of the mitogen-activated protein kinase phosphorylation sites on human Sos1 that regulate interaction with Grb2. Mol. Cell. Biol. 16, 5674-56822
48. Abrieu, A., Dorée, M., and Fisher, D. (2001) The interplay between cyclin B-Cdc2 kinase (MPF) and MAP kinase during maturation of oocytes. J. Cell Sci. 114, 257-2677
49. Abrieu, A., Dorée, M., and Picard, A. (1997) Mitogen-activated protein kinase activation down-regulates a mechanism that inactivates cyclin BCdc2 kinase in G2-arrested oocytes. Mol. Biol. Cell 8, 249-2611
50. Heald, R., McLoughlin, M., and McKeon, F. (1993) Human wee1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated Cdc2 kinase. Cell 74, 463-4744
51. King, R. W., Jackson, P. K., and Kirschner, M. W. (1994) Mitosis in transition. Cell 79, 563-5711
52. Liu, F., Stanton, J. J., Wu, Z., and Piwnica-Worms, H. (1997) The human Myt1 kinase preferentially phosphorylates Cdc2 on threonine 14 and localizes to the endoplasmic reticulum and Golgi complex. Mol. Cell. Biol. 17, 571-5833
53. Borgne, A., and Meijer, L. (1996) Sequential dephosphorylation of p34cdc2 on Thr-14 and Tyr-15 at the prophase/metaphase transition. J. Biol. Chem. 271, 27847-278544
54. Gautier, J., Solomon, M. J., Booher, R. N., Bazan, J. F., and Kirschner, M. W. (1991) Cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2. Cell 67, 197-2111
55. Krek, W., and Nigg, E. A. (1991) Mutations of p34cdc2 phosphorylation sites induce premature mitotic events in HeLa cells: evidence for a double block to p34cdc2 kinase activation in vertebrates. EMBO J. 10, 3331-33411
56. Palmer, A., Gavin, A. C., and Nebreda, A. R. (1998) A link between MAP kinase and p34cdc2/cyclin B during oocyte maturation: p90rsk phosphorylates and inactivates the p34cdc2 inhibitory kinase Myt1. EMBO J. 17, 5037-50477
57. Walsh, S., Margolis, S. S., and Kornbluth, S. (2003) Phosphorylation of the cyclin B1 cytoplasmic retention sequence by mitogen-activated protein kinase and Plx. Mol. Cancer Res. 1, 280-2899
58. Boulton, T. G., Nye, S. H., Robbins, D. J., Ip, N. Y., Radziejewska, E., Morgenbesser, S. D., DePinho, R. A., Panayotatos, N., Cobb, M. H., and Yancopoulos, G. D. (1991) ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine-phosphorylated in response to insulin and NGF. Cell 65, 663-6755
59. Seger, R., and Krebs, E. G. (1995) TheMAPKsignaling cascade. FASEB J. 9, 726-7355
60. Hatano, N., Mori, Y., Oh-hora, M., Kosugi, A., Fujikawa, T., Nakai, N., Niwa, H., Miyazaki, J., Hamaoka, T., and Ogata, M. (2003) Essential role for ERK2 mitogen-activated protein kinase in placental development. Genes Cells 8, 847-8566
61. Saba-El-Leil, M. K., Vella, F. D., Vernay, B., Voisin, L., Chen, L., Labrecque, N., Ang, S. L., and Meloche, S. (2003) An essential function of the mitogenactivated protein kinase Erk2 in mouse trophoblast development. EMBO Rep. 4, 964-9688
62. Bessard, A., Frémin, C., Ezan, F., Fautrel, A., Gailhouste, L., and Baffet, G. (2008) RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo. Oncogene 27, 5315-53255
63. Frémin, C., Ezan, F., Boisselier, P., Bessard, A., Pagès, G., Pouysségur, J., and Baffet, G. (2007) ERK2 but not ERK1 plays a key role in hepatocyte replication: an RNAi-mediated ERK2 knockdown approach in wild-type and ERK1 null hepatocytes. Hepatology 45, 1035-10455
64. Lloyd, A. C. (2006) Distinct functions for ERKs? J. Biol. 5, 133
65. Vantaggiato, C., Formentini, I., Bondanza, A., Bonini, C., Naldini, L., and Brambilla, R. (2006) ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially. J. Biol. 5, 144